Insider Transactions in Q3 2022 at Iveric Bio, Inc. (ISEE)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2022
|
Christopher Paul Simms SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,272
-16.32%
|
$134,992
$11.25 P/Share
|
|
Aug 02
2022
|
Christopher Paul Simms SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,750
+35.97%
|
-
|
|
Jul 15
2022
|
Mark S. Blumenkranz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+22.22%
|
-
|
|
Jul 05
2022
|
Anthony S Gibney EVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
7,791
-41.55%
|
$70,119
$9.41 P/Share
|